Home Healthcare Healthcare IT Australia Cardiac Imaging Software Market

Australia Cardiac Imaging Software Market Size, Share & Trends Analysis Report By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound Imaging, X-ray Imaging, Others), By Application (Diagnostic Imaging, Image Guided Treatment), By End User (Hospitals, Diagnostics Centers, Others) and Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Australia Cardiac Imaging Software Market Size

Download a Free Sample To learn more about this report,

Australia Cardiac Imaging Software Market Size

The Australia cardiac imaging software market size was valued at USD 228 million in 2025 and is projected to grow from USD 247 million in 2026 to reach USD 497 million by 2034, growing at a CAGR of 9.15% during the forecast period 2026–2034.

This growth is driven by the increasing prevalence of cardiovascular diseases (CVDs), advances in technology, and government initiatives to improve healthcare infrastructure. In addition, the rising demand for non-invasive diagnostic tools and the integration of artificial intelligence (AI) are key factors fostering market expansion.

Australia Cardiac Imaging Software Market Growth Factor

Rising Prevalence of Cardiovascular Diseases and Technological Advancements

Cardiovascular diseases are a leading cause of mortality in Australia, with over 27% of all deaths attributed to heart conditions, as reported by the Australian Institute of Health and Welfare (AIHW). An aging population and lifestyle factors, including obesity and sedentary behavior, contribute significantly to this trend.

Additionally, technological advancements in this software, such as AI-powered analytics and 3D imaging, enhance diagnostic accuracy and efficiency. In particular, MRI is gaining traction due to its superior quality. The Australian government’s initiatives, like the Medicare Benefits Schedule, promote affordable access to advanced diagnostic tools, further propelling the market. For instance, Philips Healthcare’s AI-enabled cardiac MRI solutions have been widely adopted across Australian hospitals, enabling early detection and treatment of heart diseases.

Restraining Factor

High Costs and Limited Expertise

Despite promising growth, the high costs associated with this software and equipment are significant barriers. Advanced modalities like MRI require substantial investment, which can be challenging for smaller healthcare facilities. Additionally, operational costs and maintenance add to the financial burden.

Another critical issue is the limited availability of skilled professionals trained in cardiac imaging interpretation. A 2024 report by the Royal Australian and New Zealand College of Radiologists highlights a shortage of radiologists specializing in cardiac imaging, particularly in rural and remote areas. This skill gap delays diagnostic procedures and limits the effective utilization of advanced software. Addressing these challenges through government subsidies and specialized training programs is essential for sustained market growth.

Market Opportunity

Integration of Ai and Cloud-Based Solutions

The integration of AI and cloud-based technologies presents significant opportunities for the software market. AI-powered tools streamline image analysis, providing real-time insights and improving diagnostic accuracy. For example, AI algorithms can detect minute abnormalities in cardiac structures, enabling early intervention.

In addition, cloud-based solutions offer scalability and interoperability, allowing healthcare providers to store and share imaging data seamlessly. This mainly benefits regional hospitals and diagnostic centers, enhancing collaboration and access to specialist opinions. According to the Australian Digital Health Agency, adopting cloud-based medical solutions is expected to grow by 15% annually, driven by government initiatives like My Health Record. Collaborations between technology firms and healthcare providers, such as Siemens Healthineers’ cloud-integrated platforms, pave the way for a digitally advanced cardiac care ecosystem.

Modality Inisights

Magnetic resonance imaging dominates the modality segment and is expected to grow at a CAGR of 10.8% over the forecast period, owing to its superior imaging capabilities. MRI’s ability to provide detailed images of cardiac structures and functions makes it indispensable in diagnosing complex conditions. The adoption of AI-enhanced MRI solutions, such as those offered by GE Healthcare, is boosting its demand across Australia.

Application Insights

Diagnostic imaging leads the application segment and is expected to grow at a CAGR of 9.5% during the forecast period. The increasing need for accurate, non-invasive diagnostics in managing cardiovascular diseases drives this segment. Technologies like 4D imaging are enhancing the accuracy of diagnostic imaging, with companies like Canon Medical Systems playing a pivotal role in their adoption.

End User Insights

Hospitals dominate the end-user segment and are expected to grow at a CAGR of 104% over the forecast period. Investments in advanced equipment and training programs make hospitals pivotal in driving australia cardiac imaging software market growth. Tertiary care hospitals like Royal Melbourne Hospital are early adopters of innovative solutions.

Australia Cardiac Imaging Software Market Size By Segments

Request Customizationto receive a tailored report.

Australia Cardiac Imaging Software Market Share By Segments

Speak to an Analystto discuss market opportunities.

Country Insights

The market is characterized by regional variations in healthcare infrastructure and technological adoption, with urban centers leading the growth.

Sydney, Australia’s largest city, plays a pivotal role in the market. Its advanced healthcare infrastructure and research institutions like the Victor Chang Cardiac Research Institute drive innovation. Hospitals in Sydney are early adopters of AI-enabled solutions, enhancing diagnostic precision.

Melbourne is a hub for medical research and healthcare excellence. Facilities like the Royal Melbourne Hospital and Monash Health invest heavily in cutting-edge cardiac imaging technologies. Collaborations with global players, such as Siemens Healthineers, strengthen Melbourne’s position as a market leader.

Brisbane’s growing healthcare sector focuses on improving accessibility. Public hospitals in the city are integrating advanced solutions to cater to an aging population. Initiatives like the Queensland Health Imaging Strategy support this growth.

Perth’s expanding healthcare services emphasize digital health transformation. Regional hospitals adopt cloud-based imaging platforms to improve service delivery. Partnerships with local tech firms facilitate the development of cost-effective solutions.

Adelaide is emerging as a promising market with investments in healthcare infrastructure. The South Australian government’s focus on telemedicine and remote diagnostics benefits the adoption of cardiac imaging software in underserved areas.

List of Key and Emerging Players in Australia Cardiac Imaging Software Market

  • FUJIFILM Holdings Corporation
  • Koninklijke Philips N.V
  • Siemens Healthineers AG
  • GE HealthCare
  • CANON MEDICAL SYSTEMS CORPORATION
  • NeoSoft LLC
  • Tempus AI Inc. (Arteys)
  • Pie Medical Imaging B.V. (Esaote group)
  • Medis Medical Imaging Systems B.V.
  • Circle Cardiovascular Imaging Inc.
  • SymphonyAI
  • others.

Key Industry Developments

  • June 2026: Circle Cardiovascular Imaging expanded its AI-enabled cardiac imaging software in Australia, providing advanced automated image analysis, improved workflow efficiency, and enhanced diagnostic accuracy for cardiology departments.
  • February 2026: Philips introduced upgraded cardiac imaging software with AI-assisted image reconstruction and clinical decision support, helping Australian healthcare providers improve cardiovascular diagnosis and patient management.
  • October 2025: GE HealthCare launched enhanced cardiac imaging applications featuring cloud connectivity, automated measurements, and advanced visualization tools for hospitals and diagnostic centers.
  • July 2025: Siemens Healthineers expanded its cardiovascular imaging software portfolio with advanced post-processing and AI-powered analytics to support precision cardiac care across Australia.

Report Scope

Market Metric Details & Data (2025-2034)
Market Size in 2025 USD 228 Million
Market Size in 2026 USD 248.86 Million
Market Size in 2034 USD 501.36 Million
CAGR 9.15% (2026-2034)
Base Year for Estimation 2025
Historical Data2022-2024
Forecast Period2026-2034
Study Period 2022-2034
Key Market Players FUJIFILM Holdings Corporation, Koninklijke Philips N.V, Siemens Healthineers AG, GE HealthCare, CANON MEDICAL SYSTEMS CORPORATION
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered By Modality, By Application, By End User

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

How big is the Australia Cardiac Imaging Software Market?
The Australia cardiac imaging software market size was valued at USD 228 million in 2025 and is projected to grow from USD 247 million in 2026 to reach USD 497 million by 2034.
The Australia market growth rate growing at a 9.15% from 2024 to 2034.
Rising Prevalence of Cardiovascular Diseases and Technological Advancements are the key growth factor driving the market
Currently, Magnetic resonance imaging dominates the modality segment

Author's Details


Debashree Bora

Healthcare Lead

 Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.

With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.

A PHP Error was encountered

Severity: Notice

Message: Undefined variable: relatedReports

Filename: reportpages/rd.php

Line Number: 640

Backtrace:

File: /var/www/html/application/views/frontend/reportpages/rd.php
Line: 640
Function: _error_handler

File: /var/www/html/application/controllers/FrontendRegionalReportController.php
Line: 108
Function: view

File: /var/www/html/index.php
Line: 364
Function: require_once

Report Details
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
custom reports
Need a Tailored Report?
80% of our existing clients ask for tailored reports.
Request Customization
Request Sample Order Report Now

We are featured on: